Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/21
End: 06/30/24
Due: 06/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease | NCT05047328 | ElsaLys Biotech | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD | NCT04289103 | ElsaLys Biotech | user2@example.com | None | 2021-10-31 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |